CVE:MJN Cronos Group (MJN) Stock Price, News & Analysis → New trading system called MSFT, NVDA & MSFT (From WealthPress) (Ad) Free MJN Stock Alerts C$12.15 -0.23 (-1.86%) (As of 03/2/2018) Add Compare Share Share Today's RangeC$11.90▼C$12.4750-Day RangeC$12.15▼C$12.1552-Week RangeC$1.58▼C$14.83Volume1.39 million shsAverage Volume2.07 million shsMarket CapitalizationC$1.73 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cronos Group alerts: Email Address Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $200 on Your Annual Subscription.Start Your Risk-Free Trial Here About Cronos Group Stock (CVE:MJN)Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.Read More MJN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MJN Stock News HeadlinesMay 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Cronos Group (CRON)May 9, 2024 | msn.comCronos Group (CRON) Q1 2024 Earnings Call TranscriptMay 9, 2024 | msn.comCronos Group beats top-line and bottom-line estimates; reaffirms FY24 outlookMay 9, 2024 | msn.comCronos’ stock rallies after revenue rises to a record, amid strength in cannabis flower salesMay 9, 2024 | marketwatch.comCronos Group Shares Rise on 1Q Revenue BeatFebruary 29, 2024 | marketwatch.comCronos Group 4Q Loss Narrows as New Cannabis Markets Boost RevenueFebruary 28, 2024 | benzinga.comCronos Group's Earnings: A PreviewNovember 27, 2023 | benzinga.comCronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facilitySeptember 5, 2023 | benzinga.comWhat's Going On With Cronos Group Shares?September 1, 2023 | markets.businessinsider.comCronos Group (CRON) Receives a Buy from Roth MKMAugust 31, 2023 | benzinga.comWhy Cronos Group Stock (CRON) Is SkyrocketingJuly 10, 2023 | msn.comCronos Group: Unlikely DealJuly 6, 2023 | msn.comAltria-backed cannabis producer Cronos explores sale, sources sayJuly 6, 2023 | msn.comAltria-Backed Cannabis Producer Cronos Group Considers Sale, Stock Waivers Amid Takeover InterestJune 15, 2023 | marketwatch.comCronos Group Inc. stock remains steady Thursday, underperforms marketMay 31, 2023 | markets.businessinsider.comCronos To Exit U.S. CBD OperationsMay 31, 2023 | benzinga.comCronos Group Announces Streamlined Operating Structure to Improve Cash FlowMay 21, 2023 | benzinga.comCronos Group Stock (NASDAQ:CRON), Insider Trading ActivityApril 26, 2023 | marketwatch.comCronos Group Inc. stock falls Monday, underperforms marketMarch 1, 2023 | benzinga.comCronos Group's Return On Capital Employed OverviewFebruary 25, 2023 | benzinga.comCronos Group Stock (NASDAQ:CRON), Quotes and News SummaryDecember 14, 2022 | marketwatch.comCronos Group Inc. stock outperforms market despite losses on the dayNovember 7, 2022 | marketwatch.comCronos Group Shares Decline on 3Q MissesNovember 7, 2022 | benzinga.comWhy Cronos Group Shares Are Falling SharplyOctober 26, 2022 | marketwatch.comCronos Shares Fall 5.1% After Hours On SEC Charges for Alleged Accounting FraudSee More Headlines Receive MJN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryCannabis Current SymbolCVE:MJN CUSIPN/A CIKN/A Webthecronosgroup.com Phone+1-416-5040004FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares142,653,000Free FloatN/AMarket CapC$1.73 billion OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMichael Ryan GorensteinPresident, Chief Executive Officer, Vice Chairman of the Board, Corporate SecretaryWilliam Lawrence HilsonChief Financial OfficerJason AdlerDirectorRyan RoebuckDirectorJames RudykDirectorAlan Mark Friedman (Age 45)Independent Director Michael Howard KrestellIndependent DirectorMore ExecutivesKey CompetitorsCanopy GrowthTSE:WEEDCanniMed TherapeuticsTSE:CMEDOrganigramTSE:OGIEmblemCVE:EMCICC LabsCVE:ICCView All Competitors MJN Stock Analysis - Frequently Asked Questions How have MJN shares performed in 2024? Cronos Group's stock was trading at C$12.15 at the beginning of the year. Since then, MJN shares have increased by 0.0% and is now trading at C$12.15. View the best growth stocks for 2024 here. Is Cronos Group a good dividend stock? Cronos Group (CVE:MJN) pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), Organigram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), CanniMed Therapeutics (CMED). How do I buy shares of Cronos Group? Shares of MJN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:MJN) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media ‘America’s Top Trader’ Who Predicted the Biggest Financial Events of The Last 30 Years, Issues New WARNING:InvestorPlaceNYSE biotech company's drug could be as revolutionary as penicillin!Financial Markets Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.